Literature DB >> 16502428

NTNG1 mutations are a rare cause of Rett syndrome.

Hayley L Archer1, Julie C Evans, David S Millar, Peter W Thompson, Alison M Kerr, Helen Leonard, John Christodoulou, David Ravine, Lazarus Lazarou, Lucy Grove, Christopher Verity, Sharon D Whatley, Daniela T Pilz, Julian R Sampson, Angus J Clarke.   

Abstract

A translocation that disrupted the netrin G1 gene (NTNG1) was recently reported in a patient with the early seizure variant of Rett syndrome (RTT). The netrin G1 protein (NTNG1) has an important role in the developing central nervous system, particularly in axonal guidance, signalling and NMDA receptor function and was a good candidate gene for RTT. We recruited 115 patients with RTT (females: 25 classic and 84 atypical; 6 males) but no mutation in the MECP2 gene. For those 52 patients with epileptic seizure onset in the first 6 months of life, CDKL5 mutations were also excluded. We aimed to determine whether mutations in NTNG1 accounted for a significant subset of patients with RTT, particularly those with the early onset seizure variant and other atypical presentations. We sequenced the nine coding exons of NTNG1 and identified four sequence variants, none of which were likely to be pathogenic. Mutations in the NTNG1 gene appear to be a rare cause of RTT but NTNG1 function demands further investigation in relation to the central nervous system pathophysiology of the disorder. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502428      PMCID: PMC2577736          DOI: 10.1002/ajmg.a.31133

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  33 in total

Review 1.  Neurobiology of Rett syndrome: a genetic disorder of synapse development.

Authors:  M V Johnston; O H Jeon; J Pevsner; M E Blue; S Naidu
Journal:  Brain Dev       Date:  2001-12       Impact factor: 1.961

2.  Large genomic rearrangements in MECP2.

Authors:  Kirstine Ravn; Jytte Bieber Nielsen; Ola Husbeth Skjeldal; Alison Kerr; Maj Hulten; Marianne Schwartz
Journal:  Hum Mutat       Date:  2005-03       Impact factor: 4.878

3.  Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype-phenotype associations in Rett syndrome.

Authors:  Tony Charman; Tracey C S Neilson; Veronica Mash; Hayley Archer; Mary T Gardiner; Gun P S Knudsen; Aoibhinn McDonnell; Jacqueline Perry; Sharon D Whatley; David J Bunyan; Kirstine Ravn; Rebecca H Mount; Richard P Hastings; Maj Hulten; Karen Helene Orstavik; Sheena Reilly; Hilary Cass; Angus Clarke; Alison M Kerr; Mark E S Bailey
Journal:  Eur J Hum Genet       Date:  2005-10       Impact factor: 4.246

4.  Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets.

Authors:  Yong Yin; Jeffrey H Miner; Joshua R Sanes
Journal:  Mol Cell Neurosci       Date:  2002-03       Impact factor: 4.314

5.  Early onset seizures and Rett-like features associated with mutations in CDKL5.

Authors:  Julie C Evans; Hayley L Archer; James P Colley; Kirstine Ravn; Jytte Bieber Nielsen; Alison Kerr; Elizabeth Williams; John Christodoulou; Jozef Gécz; Philip E Jardine; Michael J Wright; Daniela T Pilz; Lazarus Lazarou; David N Cooper; Julian R Sampson; Rachel Butler; Sharon D Whatley; Angus J Clarke
Journal:  Eur J Hum Genet       Date:  2005-10       Impact factor: 4.246

6.  Human netrin-G1 isoforms show evidence of differential expression.

Authors:  Joanne M A Meerabux; Hisako Ohba; Masayuki Fukasawa; Yumiko Suto; Mika Aoki-Suzuki; Toshiaki Nakashiba; Sachiko Nishimura; Shigeyoshi Itohara; Takeo Yoshikawa
Journal:  Genomics       Date:  2005-07       Impact factor: 5.736

7.  N-Methyl-D-aspartate receptor expression in the nucleus tractus solitarii and maturation of hypoxic ventilatory response in the rat.

Authors:  P J Ohtake; N Simakajornboon; M D Fehniger; Y D Xue; D Gozal
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

8.  A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia.

Authors:  Mika Aoki-Suzuki; Kazuo Yamada; Joanne Meerabux; Yoshimi Iwayama-Shigeno; Hisako Ohba; Kazuya Iwamoto; Hitomi Takao; Tomoko Toyota; Yumiko Suto; Noriaki Nakatani; Brian Dean; Sachiko Nishimura; Kenjiro Seki; Tadafumi Kato; Shigeyoshi Itohara; Toru Nishikawa; Takeo Yoshikawa
Journal:  Biol Psychiatry       Date:  2005-02-15       Impact factor: 13.382

9.  Disruption of Netrin G1 by a balanced chromosome translocation in a girl with Rett syndrome.

Authors:  Isabella Borg; Kristine Freude; Sabine Kübart; Kirsten Hoffmann; Corinna Menzel; Franco Laccone; Helen Firth; Malcolm A Ferguson-Smith; Niels Tommerup; Hans-Hilger Ropers; David Sargan; Vera M Kalscheuer
Journal:  Eur J Hum Genet       Date:  2005-08       Impact factor: 4.246

10.  CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome.

Authors:  Francesca Mari; Sara Azimonti; Ilaria Bertani; Fabrizio Bolognese; Elena Colombo; Rossella Caselli; Elisa Scala; Ilaria Longo; Salvatore Grosso; Chiara Pescucci; Francesca Ariani; Giuseppe Hayek; Paolo Balestri; Anna Bergo; Gianfranco Badaracco; Michele Zappella; Vania Broccoli; Alessandra Renieri; Charlotte Kilstrup-Nielsen; Nicoletta Landsberger
Journal:  Hum Mol Genet       Date:  2005-05-25       Impact factor: 6.150

View more
  13 in total

1.  The clasp between NetrinG and NGL becomes crystal clear.

Authors:  Jennifer S Goldman; Timothy E Kennedy
Journal:  EMBO J       Date:  2011-11-02       Impact factor: 11.598

2.  Phenotypic interpretation of complex chromosomal rearrangements informed by nucleotide-level resolution and structural organization of chromatin.

Authors:  Cinthya J Zepeda-Mendoza; Alexandra Bardon; Tammy Kammin; David J Harris; Helen Cox; Claire Redin; Zehra Ordulu; Michael E Talkowski; Cynthia C Morton
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

Review 3.  Rett Syndrome: Reaching for Clinical Trials.

Authors:  Lucas Pozzo-Miller; Sandipan Pati; Alan K Percy
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  Netrin G1 is a Novel Target Antigen in Primary Membranous Nephropathy.

Authors:  Linda Reinhard; Maya Machalitza; Thorsten Wiech; Hermann-Josef Groene; Moritz Lassé; Markus Rinschen; Nicoletta Ferru; Jan Bräsen; Friederike Drömann; Peter Rob; Sanjeev Sethi; Elion Hoxha; Rolf Stahl
Journal:  J Am Soc Nephrol       Date:  2022-08-19       Impact factor: 14.978

5.  Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome.

Authors:  Heather E Olson; Dimira Tambunan; Christopher LaCoursiere; Marti Goldenberg; Rebecca Pinsky; Emilie Martin; Eugenia Ho; Omar Khwaja; Walter E Kaufmann; Annapurna Poduri
Journal:  Am J Med Genet A       Date:  2015-04-25       Impact factor: 2.802

Review 6.  Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics.

Authors:  Ling Lin; Timothy G Lesnick; Demetrius M Maraganore; Ole Isacson
Journal:  Trends Neurosci       Date:  2009-01-21       Impact factor: 13.837

7.  Rett syndrome molecular diagnosis and implications in genetic counseling.

Authors:  M Noruzinia; M T Akbari; M Ghofrani; H Sheikhha
Journal:  Indian J Hum Genet       Date:  2007-09

8.  When Rett syndrome is due to genes other than MECP2.

Authors:  Alan K Percy; Jane Lane; Fran Annese; Hannah Warren; Steven A Skinner; Jeffrey L Neul
Journal:  Transl Sci Rare Dis       Date:  2018-04-13

Review 9.  The netrin protein family.

Authors:  Sathyanath Rajasekharan; Timothy E Kennedy
Journal:  Genome Biol       Date:  2009-09-29       Impact factor: 13.583

10.  Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke.

Authors:  Ana-Maria Buga; Claus Jürgen Scholz; Senthil Kumar; James G Herndon; Dragos Alexandru; Gabriel Radu Cojocaru; Thomas Dandekar; Aurel Popa-Wagner
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.